07/21/2026
We're proud to recognize our physicians and fellow who recently presented at the 2026 American Society of Retina Specialists (ASRS) Annual Meeting in Montréal, Canada.
Each year, the ASRS Annual Meeting brings together retina specialists from around the world to share the latest research, clinical insights, and surgical innovations. This year, Tennessee Retina was honored to have five presenters contributing to the scientific program:
🗣️ Carl C. Awh, MD, FASRS – Moderated the Surgical Case Conference, presented late-breaking clinical trial results on investigational gene therapy for neovascular AMD, and was honored with the 2026 ASRS Founders Award.
🗣️ Franco M. Recchia, MD – Presented research on retinal detachment following prophylactic retinopexy in children with Stickler syndrome.
🗣️ David A. Reichstein, MD, FASRS – Presented research on mutation profiling and risk assessment in uveal melanoma during the Ocular Oncology Symposium.
🗣️ Eric W. Schneider, MD, FASRS – Presented 24-week results from the Phase 3b ELARA trial evaluating aflibercept 8 mg in patients with neovascular AMD and diabetic macular edema.
🗣️ Mitchell T. Allphin, MD – Our second-year Vitreoretinal Surgery Fellow presented research evaluating the safety of anti-VEGF injections in patients with uveitis, including the impact of systemic immunosuppression on infection risk.
Congratulations to Drs. Awh, Schneider, Reichstein, Recchia, and Allphin for representing Tennessee Retina and contributing to this year's scientific program!